Position in SVRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$23,852,338
+$4,226,478 QoQ
Shares Held
3,872,133
+7.7% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 181 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. SVRA ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SVRA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,852,338 | 3,872,133 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $19,625,860 | 3,594,480 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,609,146 | 3,417,769 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,980,508 | 2,795,661 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,772,016 | 2,970,183 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,817,595 | 2,822,237 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,546,993 | 2,784,037 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,561,843 | 2,726,850 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,921,960 | 2,462,025 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $11,791,668 | 2,367,805 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,936,303 | 2,326,873 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,397,224 | 2,221,488 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,858,604 | 1,833,679 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,091,088 | 1,072,353 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,573,578 | 1,015,212 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,567,389 | 1,011,219 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,629,975 | 1,072,352 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,573,675 | 1,201,279 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,484,735 | 1,197,367 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,653,460 | 1,198,160 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,917,292 | 1,127,819 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,634,828 | 785,975 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $667,362 | 580,315 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $632,394 | 580,178 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,426,182 | 572,764 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,014,000 | 478,302 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||